Site url:
Pagecontext: org.apache.jasper.runtime.PageContextImpl@cda408b
page.keywordsOffshore investing

Mark Wright | 09 August 2021

Value is in the Eye
of the Beholder

Share this article

In her 19th century novel, ‘Molly Bawn’, Irish novelist, Margaret Wolfe Hungerford, is credited with paraphrasing a statement made about beauty by Athenian philosopher and founder of the first institution of higher learning in the Western world, Plato.

“Beauty is in the eyes of the beholder” is a phrase I’ve often found myself replying in retort – we are sadly not all blessed with looks that appeal to the masses! The concept of beauty has been a topic for debate preceding Christ and almost certainly precedes value investing, but I would suggest that it is not just beauty that is in the eyes of the beholder, but also value.

Chinese philosopher, Confucius, stated that “everything has beauty, but not everyone sees it”. The UK equity market certainly has value, but it appears to only be corporates and private equity investors, rather than traditional investors in the UK public equity market that presently see it.

The first half of 2021 has seen 124 takeovers and purchases of minority stakes in UK companies by private companies, totalling some £41.5bn. This is the highest value recorded by Dealogic since the company started tracking deals in 2005. London listed companies have comprised 21 of that 124, with an equity value of £24.4bn. 1

Four of those 21 London listed companies were, or still are, held in the direct UK equity portfolio we manage for our clients. A pleasingly high hit rate in what is a relatively concentrated portfolio of 24 holdings; we do not believe in diluting conviction with an unwarranted proliferation of holdings.

The first investment to be subject to takeover was Marston’s in January when it was revealed that private equity outfit, Lone Star, had tabled an all cash offer at 105p per share; a 40% premium to the closing price on 28th January and a whopping 373% premium to the level at which the shares were trading in the depths of the market sell off last year. That said, it only valued the pub operator and brewer at £665m, a 10% discount to the company’s net asset value prior to the pandemic. The Board dutifully rejected the offer.

Quickly following on from Marston’s, the second was Arrow Global in early February when private equity group, TDR Capital, made a revised offer of 307.5p per share for the debt investor and fund management business. The premium was a healthy 33% to the prior day’s closing price and a huge 406% premium to share price lows witnessed less than 12 months earlier.

The two most recent examples within the direct UK equity portfolio are within the Aerospace and Defence sector, namely Senior and Ultra Electronics. Senior ultimately rejected a final offer at 200p per share from the same private equity group that bid for Marston’s, despite it being an appealing 69% premium to the undisturbed share price before Lone Star first made an offer in May and a massive 367% premium to the share price low in 2020.

Jim Henson, creator of The Muppets characters, comically said “Beauty is in the eye of the beholder and it may be necessary from time to time to give a stupid or misinformed beholder a black eye”. Lone Star have certainly found themselves with a black eye or two!

Ultra Electronics has been bid for by Cobham at 3,516p per share, equivalent to a 42% premium to the prior day’s closing share price. Cobham itself was victim to takeover less than two years ago when the public market failed to see the value in its equity, post the completion of a turnaround project of some magnitude by CEO, David Lockwood. We now expect Mr Lockwood to achieve similar results at Babcock International (one of our other 24 high conviction holdings). Babcock International is an engineering group that services the entire British fleet of nuclear submarines, as well as the majority of its naval fleet.

At times, the public equity market is very poor at seeing value and this is evidently the case with respect to the UK equity market currently. The UK’s headline indices trade at substantial discounts to other international indices in both absolute terms and relative to each index’s own history. We believe the direct UK equity portfolio we manage remains even more undervalued.

Why is it right now that the private equity industry can see value in the UK public equity market, but traditional equity investors cannot? Perhaps it has something to do with patience… whilst the average holding period of UK equity investments has declined from as long as 10 years in 1980 to just 8 months now2, holding periods within the private equity industry have been increasing recently to over 5 years3.

We do not assume any M&A will help generate returns when investing in what we perceive as materially undervalued UK equities, but similar to Russian mathematician, Ivan Panin, who is quoted as saying “For every beauty there is an eye somewhere to see it”, we do believe that “For every value opportunity, there is a potential acquirer somewhere to see it”.

1 Record value of UK companies taken over in 2021 so far - and M&A set to continue (
2 Investment Statistics: Are Brits investing in stocks and shares? | Finder UK
3 Private equity holding periods reach all-time high in 2020 (

Share this article

In case you missed it

26 JULY 2021

A Summer of Competition

By Jackson Franks

There was one competition that may have caught your eye, the billionaire’s race to space. The advances in technology within the space sector is evolutionary. However, do the benefits outweigh the
environmental risks?

26 JULY 2021

All eyes on the US

By Michael Clough

“Should you be over or underweight the US equity market?” is surely one of the most asked asset allocation questions of the past five to ten years. But what about going forward?

19 JULY 2021

Value Investing Redux

By Tom Delic

Benjamin Graham’s ‘Intelligent Investor’, first published in 1949, has provided the philosophical foundation to thousands of investors over the years. What can we learn from the book today?

We and our selected partners use cookies to enhance and personalise your experience on our website.Please see our cookie policy for more information.

To enhance your user experience on our site, learn more about our supported browsers

Your browser's cookies are disabled. Enable cookies to ensure our website functions correctly. View our Privacy Notice.

Tell us more!

We're always looking for ways to improve your online experience. Please take a moment to complete the
2-minute questionnaire.